Fallopian tube cancer as a feature of BRCA1-associated syndromes [1] (multiple letter)

Gynecologic Oncology

Volumn 78, Issue 2, 2000, Pages 263-264

  Sobol, Hagay ^a   Jacquemier, Jocelyne ^a   Bonaiti, Catherine ^b   Dauplat, Jacques ^c   Birnbaum, Daniel ^a,d   Eisinger, François ^a,d   Verheijen, René H M ^e  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CENTRE JEAN PERRIN   (France)

^d INSERM   (France)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER LOCALIZATION; CASE REPORT; CHROMOSOME 17Q; FEMALE; GENE MUTATION; GENETIC LINKAGE; HAPLOTYPE; HUMAN; LETTER; MOLECULAR CLONING; OVARIECTOMY; PRIORITY JOURNAL; SYNDROME; UTERINE TUBE TUMOR;

EID: 0033849196     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5897     Document Type: Editorial

References (5)

1. RP Zweemer PJ van Diest RH Verheijen Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations Gynecol Oncol 76 2000 45 50
2. E Steichen-Gersdorf H Gallion D Ford Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21 Am J Hum Genet 55 1994 870 875
3. L Essioux C Girodet O Sinilnikova Marker segregation information in breast/ovarian cancer genetic counselling: is it still useful? Groupe Genetique et Cancer de la Federation Nationale des Centres de Lutte Contre le Cancer Am J Med Genet 79 1998 175 183
4. N Puget D Stoppa-Lyonnet O Sinilnikova Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions Cancer Res 59 1999 455 461
5. F Eisinger N Alby A Bremond Recommendations for medical management of hereditary breast ovarian cancer: The French National Ad Hoc Committee Ann Oncol 9 1998 939 950